1. Home
  2. LSTA vs GLBS Comparison

LSTA vs GLBS Comparison

Compare LSTA & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GLBS
  • Stock Information
  • Founded
  • LSTA 1980
  • GLBS 2006
  • Country
  • LSTA United States
  • GLBS Greece
  • Employees
  • LSTA N/A
  • GLBS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GLBS Marine Transportation
  • Sector
  • LSTA Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • LSTA 31.2M
  • GLBS 28.2M
  • IPO Year
  • LSTA N/A
  • GLBS 2007
  • Fundamental
  • Price
  • LSTA $3.71
  • GLBS $1.31
  • Analyst Decision
  • LSTA Strong Buy
  • GLBS
  • Analyst Count
  • LSTA 1
  • GLBS 0
  • Target Price
  • LSTA $15.00
  • GLBS N/A
  • AVG Volume (30 Days)
  • LSTA 53.5K
  • GLBS 63.4K
  • Earning Date
  • LSTA 02-27-2025
  • GLBS 03-14-2025
  • Dividend Yield
  • LSTA N/A
  • GLBS N/A
  • EPS Growth
  • LSTA N/A
  • GLBS 61.29
  • EPS
  • LSTA N/A
  • GLBS 0.14
  • Revenue
  • LSTA N/A
  • GLBS $33,289,000.00
  • Revenue This Year
  • LSTA N/A
  • GLBS $15.39
  • Revenue Next Year
  • LSTA N/A
  • GLBS $43.34
  • P/E Ratio
  • LSTA N/A
  • GLBS $9.60
  • Revenue Growth
  • LSTA N/A
  • GLBS 2.74
  • 52 Week Low
  • LSTA $2.19
  • GLBS $1.06
  • 52 Week High
  • LSTA $4.20
  • GLBS $2.42
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 66.07
  • GLBS 50.57
  • Support Level
  • LSTA $3.52
  • GLBS $1.26
  • Resistance Level
  • LSTA $3.87
  • GLBS $1.36
  • Average True Range (ATR)
  • LSTA 0.29
  • GLBS 0.08
  • MACD
  • LSTA 0.02
  • GLBS 0.02
  • Stochastic Oscillator
  • LSTA 63.97
  • GLBS 60.61

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: